DUE to Bristol-Myers Squibb
(BMS) being found in breach of
sections of the Medicines Australia
(MA) Code of Conduct on certain
matters relating to a doctor
meeting, the company has been
ordered to pay a fine of $10,000.
Bizarrely, when rival MSD
appealed the sanction as too
limited, but lost the appeal, the
Medicines Australia Appeals
Committee retained the company’s
$20,000 appeal bond, meaning the
matter cost MSD twice as much as
the original BMS fine.The above article was sent to subscribers in Pharmacy Daily's issue from 02 Aug 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Aug 16
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.